Key Considerations for Commercializing a Compound - - BioPharm International

ADVERTISEMENT

Key Considerations for Commercializing a Compound


blog comments powered by Disqus


Joerg Zimmerman, director of process development and implementation at Vetter discusses the need to think carefully about the commercialization efforts that must be applied to a compound under development. Providing real world examples, Zimmerman runs through the technical challenges that biotech companies commonly face in drug development and offers some sound advice to facilitate the process. Zimmerman also talks on the regulatory focus on considering biological formulations in prefilled syringes as combination products and the need to establish compatibility at an early stage in development. Posted Feb. 2012.

Related article: Playing the Drug Development Game

ADVERTISEMENT

ADVERTISEMENT

NIH Launches Human Safety Study of Ebola Vaccine Candidate
August 29, 2014
Suppliers Seek to Boost Single-Use Technology
August 21, 2014
Bristol-Myers Squibb and Celgene Collaborate on Immunotherapy and Chemotherapy Combination Regimen
August 20, 2014
FDA Warns about Fraudulent Ebola Treatments
August 15, 2014
USP Awards Analytical Research
August 15, 2014
Author Guidelines

Click here